<code id='4E645F56B8'></code><style id='4E645F56B8'></style>
    • <acronym id='4E645F56B8'></acronym>
      <center id='4E645F56B8'><center id='4E645F56B8'><tfoot id='4E645F56B8'></tfoot></center><abbr id='4E645F56B8'><dir id='4E645F56B8'><tfoot id='4E645F56B8'></tfoot><noframes id='4E645F56B8'>

    • <optgroup id='4E645F56B8'><strike id='4E645F56B8'><sup id='4E645F56B8'></sup></strike><code id='4E645F56B8'></code></optgroup>
        1. <b id='4E645F56B8'><label id='4E645F56B8'><select id='4E645F56B8'><dt id='4E645F56B8'><span id='4E645F56B8'></span></dt></select></label></b><u id='4E645F56B8'></u>
          <i id='4E645F56B8'><strike id='4E645F56B8'><tt id='4E645F56B8'><pre id='4E645F56B8'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:849
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          The response to Covid
          The response to Covid

          AdobeInMarch,ateamofChinesescientistsstudyingwhethertheantiviralremdesivirwaseffectiveagainstCovid-1

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Clinic falsely told dozens they had Alzheimer's, suits say

          ShawnBlazsekwasoneofseveralpatientstoldincorrectlythathehadAlzheimer'sdiseasebyaclinicunderinvestiga